• Exchange: OTC US
  • Sector: Industrials
  • Industry: Electrical Equipment
  • Sub-Industry: Comml & Res Bldg Equip & Sys

Global Immune Technologies Inc

+ Add to Watchlist

GIMU:US

0.0015 USD 0.0002 11.76%

As of 20:10:00 ET on 08/25/2014.

Snapshot for Global Immune Technologies Inc (GIMU)

Open: 0.0015 Day's Range: 0.0015 - 0.0015 Volume: 18,500
Previous Close: 0.0017 52wk Range: 0.0011 - 0.0380 1-Yr Rtn: -95.71%

Stock Chart for GIMU

No chart data available.
  • GIMU:US 0.0015
  • 1D
  • 1M
  • 1Y
0.0017
Interactive GIMU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GIMU

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0040
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.24
Shares Outstanding (M) 157.35
30 Day Average Volume 14,333
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GIMU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GIMU

Global Immune Technologies, Inc. owns all rights and interests to the drug Trioxolane. The drug acts to reinforce the natural immune system and regulate the production of serotonin, prostaglandin and inflammatory interleukins.

David Michael HolbrookPresident/CEODavid R FrankCFO/Secretary
More Company Profile & Key Executives for GIMU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil